Transdermal Drug Delivery Patches Market, Global Outlook and Forecast 2022-2028

0
5

This report contains market size and forecasts of Transdermal Drug Delivery Patches in global, including the following market information:
Global Transdermal Drug Delivery Patches Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transdermal Drug Delivery Patches Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transdermal Drug Delivery Patches companies in 2021 (%)
The global Transdermal Drug Delivery Patches market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Methyl Salicylate-based Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal Drug Delivery Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal and IBSA Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal Drug Delivery Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Drug Delivery Patches Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal Drug Delivery Patches Market Segment Percentages, by Type, 2021 (%)
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Transdermal Drug Delivery Patches Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal Drug Delivery Patches Market Segment Percentages, by Application, 2021 (%)
Rx Channel
OTC Channel
Global Transdermal Drug Delivery Patches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal Drug Delivery Patches Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Drug Delivery Patches revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transdermal Drug Delivery Patches revenues share in global market, 2021 (%)
Key companies Transdermal Drug Delivery Patches sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transdermal Drug Delivery Patches sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Gr?nenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy?s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.